Search

Your search keyword '"Jia, Rulin"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Jia, Rulin" Remove constraint Author: "Jia, Rulin"
43 results on '"Jia, Rulin"'

Search Results

Catalog

Books, media, physical & digital resources

14. Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

19. Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjögren's syndrome

25. Mitochondrial genome sequencing with short overlapping amplicons on MiSeq FGx system.

26. p-Pyridine BODIPY-based fluorescence probe for highly sensitive and selective detection of picric acid

27. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial

30. Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients

31. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.

35. Association ofSTAT4gene polymorphism with increased susceptibility of rheumatoid arthritis in a northern Chinese Han subpopulation

37. Low-dose interleukin-2 treatment selectively modulates CD4+T cell subsets in patients with systemic lupus erythematosus

38. Prevalence and Significance of Anti-Peptidylarginine Deiminase 4 Antibodies in Rheumatoid Arthritis

39. Nitrogen-doped carbon quantum dots (NCQDs) detected to mercury ions in food monitoring.

40. [Analysis of characteristics related to the disease activity of systemic lupus erythematosus and construction of an evaluation model].

41. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.

42. Lipopolysaccharide-binding protein is a sensitive disease activity biomarker for rheumatoid arthritis.

43. Impact of rheumatoid arthritis-associated HLA-DRbeta1 subtypes on protein kinase A signaling.